Science 37 to Present at the Baird 2022 Global Healthcare Conference
September 08 2022 - 4:01PM
Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial
Operating System™, today announced the company will be
participating in the upcoming Baird Global Healthcare Conference in
New York.
Science 37’s management is scheduled to present on Tuesday,
September 13, 2022, at 3:45 p.m. Eastern Time. Interested parties
may access a live and archived webcast of the presentation on the
“Investor Relations” section of the company’s website at:
https://investors.science37.com.
About Science 37Science 37 Holdings, Inc.’s
(Nasdaq: SNCE) mission is to enable universal access to clinical
research—making it easier for patients and providers to participate
from anywhere and helping to accelerate the development of
treatments that impact patient lives. As a pioneer of decentralized
clinical trials, the Science 37 l Operating System (OS) supports
today’s more agile clinical research designs with its full stack,
end-to-end technology platform and centralized networks of patient
communities, telemedicine investigators, mobile nurses, remote
coordinators, provider communities, and data and devices.
Configurable to enable almost any study type, the Science 37 OS
enables up to 21x faster enrollment, 28% better retention and 3x
more diverse patient population with industry-leading workflow
orchestration, evidence generation and data harmonization. For more
information, visit https://www.science37.com.
MEDIA INQUIRIES
Drew BustosScience 37Phone: (984) 377-3737Email:
pr@science37.com
INVESTOR RELATIONS:Caroline PaulGilmartin
GroupInvestors@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Apr 2023 to Apr 2024